Position in NVS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$290,401
+$7,967 QoQ
Shares Held
1,853
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,149
of 1,603 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ascentis Wealth Management, LLC holds $15,135,875 across 14 Drug Manufacturers - General names. NVS ranks #10 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
24,100 | $6,064,446 | |
| 2 | AMGN |
Amgen Inc
|
6,909 | $2,501,833 | |
| 3 | PFE |
Pfizer Inc
|
81,054 | $1,951,737 | |
| 4 | JNJ |
Johnson & Johnson
|
6,935 | $1,761,242 | |
| 5 | LLY |
ELI LILLY & Co
|
787 | $943,936 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,580 | $452,275 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,242 | $359,642 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,647 | $340,138 |
All Filings in NVS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $290,401 | 1,853 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $282,434 | 1,849 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $250,371 | 1,816 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $232,883 | 1,816 | Shares | Sole | 2025-10-24 | |
| 2024-12-31 | $3,210 | 33 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $3,795 | 33 | Shares | Sole | 2024-10-11 | |
| No filing history on record for this holder in this stock. | ||||||